Publications by authors named "Chiara Zecca"

Claim this Profile
F
From diagnosis to treatment: patterns in disease-modifying therapy initiation in multiple sclerosis.
Stefania Iaquinto, Mina Stanikić, Enriqueta Vallejo-Yagüe, Jens Kuhle, Zina-Mary Manjaly, Chiara Zecca

Ther Adv Neurol Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin, Chiara Zecca

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Johanna Oechtering, Chiara Zecca

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully-automated estimation of upper cervical cord cross-sectional area using pontomedullary junction referencing in multiple sclerosis.
Roberto Masciullo, Annine Sutter, Rosaria Sacco, Nicola Pinna, Daniela Distefano, Chiara Zecca

Front Neuroimaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, Pascal Benkert, W John Boscardin, Chiara Zecca

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide survey.
Lukas Steinegger, Veronika Kana, Caroline Pot, Claudio Gobbi, Michael Weller, Chiara Zecca

Mult Scler Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple Sclerosis.
Giulio Disanto, Rosaria Sacco, Giulia Mallucci, Chiara Zecca, Claudio Gobbi

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia.
Patrizia Pignataro, Manuela Dicarlo, Chiara Zecca, Daniele Urso, Maria Teresa Dell'Abate

Ann Clin Transl Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.
Xinjie Chen, Po-Jui Lu, Mario Ocampo-Pineda, Alessandro Cagol, Sabine Anna Schaedelin, Chiara Zecca

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striatal dopaminergic patterns and clinical features in frontotemporal dementia.
Daniele Urso, Antonio Anastasia, Valentina Gnoni, Alessia Giugno, Davide Vilella, Chiara Zecca

Brain Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over.
Mina Stanikić, Anke Salmen, Christian P Kamm, Patrick Roth, Pasquale Calabrese, Chiara Zecca

BMJ Neurol Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, Pascal Benkert, Cathrine Axfors

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients: A Pilot Study.
Rosa Di Lorenzo, Chiara Zecca, Guglielmina Chimienti, Tiziana Latronico, Grazia Maria Liuzzi

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, Amit Bar-Or, Viviane Bohner-Lang, Chiara Zecca

Mult Scler· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swiss Quality of Life and Health Care Impact Assessment in a Real-World Erenumab-Treated Migraine Population: Results over 2 years.
Andreas R Gantenbein, Christian P Kamm, Christoph J Schankin, Chiara Zecca, Dominik Zieglgänsberger

Headache· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.
Giovanni Novi, Francesca Bovis, Chiara Sciolla, Jessica Frau, Matteo Minetti, Chiara Zecca

CNS Drugs· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, Pascal Benkert, Lester Melie-Garcia, Chiara Zecca

J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics feature similarity: A novel approach for characterizing brain network changes in patients with behavioral variant frontotemporal dementia.
Salvatore Nigro, Marco Filardi, Benedetta Tafuri, Roberto De Blasi, Maria Teresa Dell'Abate, Chiara Zecca

Neuroimage Clin· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donanemab eligibility in early Alzheimer's disease: A real-world study.
Daniele Urso, Alessandro Introna, Valentina Gnoni, Alessia Giugno, Davide Vilella, Chiara Zecca

J Alzheimers Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmed Worsening of Health-Related Quality of Life to Monitor Long-Term MS Disease Progression: A Longitudinal Analysis From the Swiss Multiple Sclerosis Registry.
Stefania Iaquinto, Benjamin Victor Ineichen, Mina Stanikić, Jens Kuhle, Christian Philipp Kamm, Chiara Zecca

Eur J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Constance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, Chiara Zecca, Giancarlo Logroscino

Alzheimers Dement· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.
Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, Aleksandra Maleska Maceski, Lester Melie-Garcia, Chiara Zecca

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist.
Marco Michelutti, Daniele Urso, Benedetta Tafuri, Valentina Gnoni, Alessia Giugno, Chiara Zecca

J Alzheimers Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?
Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, Xavier Ayrignac, Patrick Vermersch

Mult Scler J Exp Transl Clin· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, Johannes Lorscheider, Riccardo Galbusera, Chiara Zecca

Mult Scler J Exp Transl Clin· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis